The exact mechanism underlying this effect remains unclear; however, depression is associated with brain insulin resistance, and GLP-1 agonists have been found to prevent insulin receptor loss in the brain (Hamer et al. 2019; Lyra e Silva et al. 2019; Batista et al. 2018). This evidence concerns the gene GLP1R and depressive symptom measurement.